Home › Funds › Tri Locum Partners LP › JNJ
Tri Locum Partners LP position in JNJ
JOHNSON JOHNSON · Health Care
Tri Locum Partners LP reported holding 424,945 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$107.9M, representing 13.27% of its reported portfolio and ranking #1 among its reported holdings. Tri Locum Partners LP has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's JNJ position evolved
Tri Locum Partners LP first disclosed a stake in JNJ in Q3 2025 at 302,831 shares (US$56.2M). The position peaked in Q4 2025 at 603,143 shares, worth US$124.8M. Across 4 filings, Tri Locum Partners LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 424,945 shares valued at US$107.9M — an increase of 10,442 shares quarter over quarter.. Notable position changes include a 99% increase in Q4 2025 (shares rose 18% over the following quarter), a 31% trim in Q1 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 302.83K | $56.15M | New |
| Q4 2025 | 603.14K | $124.82M | Add |
| Q1 2026 | 414.50K | $101.32M | Reduce |
| Q2 2026 | 424.94K | $107.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JNJ and 13F data
JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JNJ
- BlackRock Inc 212.10M sh · $53.87B · Q2 2026
- Vanguard Group 240.35M sh · $49.74B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 157.23M sh · $39.93B · Q2 2026
- STATE STREET CORP 133.48M sh · $32.63B · Q1 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 64.37M sh · $16.35B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 59.09M sh · $14.97B · Q2 2026
- Geode Capital Management 59.09M sh · $14.97B · Q2 2026
- Morgan Stanley 44.81M sh · $11.38B · Q2 2026
- Norges Bank Investment Management 31.83M sh · $8.08B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 31.59M sh · $8.02B · Q2 2026
- Northern Trust Corp 28.79M sh · $7.31B · Q2 2026
- Bank of America Corp 23.44M sh · $5.95B · Q2 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held JNJ?
Tri Locum Partners LP has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Tri Locum Partners LP's current position in JNJ?
As of Q2 2026, Tri Locum Partners LP holds 424.94K shares of JNJ (JOHNSON JOHNSON), valued at $107.92M, representing 13.27% of its reported portfolio and ranking #1.
Has Tri Locum Partners LP been buying or selling JNJ?
In the latest 13F filing (Q2 2026), Tri Locum Partners LP increased its position in JNJ. The position peaked in Q4 2025 at 603.14K shares.
Which other funds hold JNJ?
Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.